Wejo Group Ltd

$ Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000186444822000015 Filed on March 31, 2022

Income Statement

Concept	2021 Q4	2021 Q3	2021 Q2

Balance Sheet

Concept	2021 Q4	2021 Q3	2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$67.32M	$8.611M	$750.0K
YoY Change
Cash & Equivalents	$67.32M	$8.611M	$15.28M
Short-Term Investments
Other Short-Term Assets	$600.0K	$12.58M	$330.0K
YoY Change	102.7%
Inventory
Prepaid Expenses	$12.34M	$2.020M
Receivables	$1.416M	$930.0K	$609.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$131.9M	$22.12M	$26.86M
YoY Change	523.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$651.0K	$603.0K	$485.0K
YoY Change	103.44%
Goodwill
YoY Change
Intangibles		$9.917M
YoY Change
Long-Term Investments			$230.0M
YoY Change
Other Assets	$0.00		$160.0K
YoY Change
Total Long-Term Assets	$10.14M	$10.52M	$10.78M
YoY Change	-9.99%
TOTAL ASSETS
Total Short-Term Assets	$131.9M	$22.12M	$26.86M
Total Long-Term Assets	$10.14M	$10.52M	$10.78M
Total Assets	$142.0M	$32.64M	$37.64M
YoY Change	337.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.43M	$7.282M	$4.808M
YoY Change	215.6%
Accrued Expenses	$21.09M	$20.96M	$14.75M
YoY Change	113.21%
Deferred Revenue	$0.00		$12.81M
YoY Change	-100.0%
Short-Term Debt	$0.00	$34.00K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$36.80M	$28.27M	$32.55M
YoY Change	11.43%
LONG-TERM LIABILITIES
Long-Term Debt	$33.71M	$35.12M
YoY Change
Other Long-Term Liabilities	$0.00	$126.9M	$39.46M
YoY Change	-100.0%
Total Long-Term Liabilities	$0.00	$162.0M	$39.46M
YoY Change	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$36.80M	$28.27M	$32.55M
Total Long-Term Liabilities	$0.00	$162.0M	$39.46M
Total Liabilities	$94.31M	$155.7M	$155.4M
YoY Change	19.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$370.0M	-$275.1M	-$254.3M
YoY Change	143.14%
Common Stock	$94.00K
YoY Change	161.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$47.69M	-$123.0M	-$117.7M
YoY Change
Total Liabilities & Shareholders Equity	$142.0M	$32.64M	$37.64M
YoY Change	337.91%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021 Q2

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001864448
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q2	dei	Entity Public Float EntityPublicFloat	0	USD
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-41091
CY2021	dei	Entity Registrant Name EntityRegistrantName	Wejo Group Limited
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1611674
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	Canon’s Court
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	22 Victoria Street
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Hamilton
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	HM12
CY2021	dei	Entity Address Country EntityAddressCountry	BM
CY2021	dei	City Area Code CityAreaCode	44 8002
CY2021	dei	Local Phone Number LocalPhoneNumber	343065
CY2021	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2021	dei	Trading Symbol TradingSymbol	WEJO
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	94666196	shares
CY2021	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2021	dei	Auditor Location AuditorLocation	Manchester, United Kingdom
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67322000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14421000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1416000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	688000	USD
CY2021Q4	wejo	Forward Purchase Agreement Current ForwardPurchaseAgreementCurrent	45611000	USD
CY2020Q4	wejo	Forward Purchase Agreement Current ForwardPurchaseAgreementCurrent	0	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17518000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6053000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	131867000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	21162000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	651000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	320000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9489000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10946000	USD
CY2021Q4	us-gaap	Assets Assets	142007000	USD
CY2020Q4	us-gaap	Assets Assets	32428000	USD
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1464000	USD
CY2020Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	2407000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	15433000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4890000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21089000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9891000	USD
CY2021Q4	wejo	Contract With Customer Related Party Liability Current ContractWithCustomerRelatedPartyLiabilityCurrent	0	USD
CY2020Q4	wejo	Contract With Customer Related Party Liability Current ContractWithCustomerRelatedPartyLiabilityCurrent	4333000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8120000	USD
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	0	USD
CY2020Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	10129000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	282000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2020Q4	wejo	Exchangeable Right Liability Noncurrent ExchangeableRightLiabilityNoncurrent	0	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	84000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	94313000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	36804000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	33030000	USD
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	6130000	USD
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2020Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	39780000	USD
CY2021Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	33705000	USD
CY2020Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	0	USD
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	12650000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2021Q4	wejo	Exchangeable Right Liability Noncurrent ExchangeableRightLiabilityNoncurrent	11154000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	79024000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.001
CY2020Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	634000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	634000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93950205	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93950205	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36463696	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36463696	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	94000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	36000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	415304000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	105835000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-369951000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10173000	USD
CY2021	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	4411000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-152173000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2247000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-294000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	47694000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-46596000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	142007000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32428000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2566000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1336000	USD
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	3583000	USD
CY2020	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1688000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26265000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7683000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	22920000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7039000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	104144000	USD
CY2020	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	4077000	USD
CY2021	wejo	Costs And Operating Expenses CostsAndOperatingExpenses	161323000	USD
CY2020	wejo	Costs And Operating Expenses CostsAndOperatingExpenses	30660000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-158757000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-29324000	USD
CY2021	wejo	Gain Loss On The Issuance Of Debt GainLossOnTheIssuanceOfDebt	-53967000	USD
CY2020	wejo	Gain Loss On The Issuance Of Debt GainLossOnTheIssuanceOfDebt	-16036000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-25598000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	12922000	USD
CY2020	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-11133000	USD
CY2021	wejo	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	13800000	USD
CY2020	wejo	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	0	USD
CY2021	wejo	Unrealized Gain Loss On Forward Purchase Agreement UnrealizedGainLossOnForwardPurchaseAgreement	-15609000	USD
CY2020	wejo	Unrealized Gain Loss On Forward Purchase Agreement UnrealizedGainLossOnForwardPurchaseAgreement	0	USD
CY2021	wejo	Unrealized Gain Loss On Exchangeable Right Liability UnrealizedGainLossOnExchangeableRightLiability	34452000	USD
CY2020	wejo	Unrealized Gain Loss On Exchangeable Right Liability UnrealizedGainLossOnExchangeableRightLiability	0	USD
CY2021	wejo	Gain Loss On Issuance Of Forward Purchase Agreement GainLossOnIssuanceOfForwardPurchaseAgreement	-11674000	USD
CY2020	wejo	Gain Loss On Issuance Of Forward Purchase Agreement GainLossOnIssuanceOfForwardPurchaseAgreement	0	USD
CY2021	wejo	Gain Loss On Settlement Of Forward Purchase Agreement GainLossOnSettlementOfForwardPurchaseAgreement	399000	USD
CY2020	wejo	Gain Loss On Settlement Of Forward Purchase Agreement GainLossOnSettlementOfForwardPurchaseAgreement	0	USD
CY2021	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements Related Party GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreementsRelatedParty	-3665000	USD
CY2020	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements Related Party GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreementsRelatedParty	-769000	USD
CY2021	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-4470000	USD
CY2020	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-1878000	USD
CY2021	us-gaap	Interest Expense InterestExpense	9597000	USD
CY2020	us-gaap	Interest Expense InterestExpense	2594000	USD
CY2021	wejo	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	606000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	678000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	687000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-217421000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-60278000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	357000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-217778000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-60278000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2541000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2555000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-215237000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-62833000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.00
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.00
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.66
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.66
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43553504	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43553504	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43553504	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43553504	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36285113	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36285113	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36285113	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36285113	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	3830000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1004000	USD
CY2020	wejo	Adjustments To Additional Paid In Capital Convertible Debt Discount AdjustmentsToAdditionalPaidInCapitalConvertibleDebtDiscount	9954000	USD
CY2020	wejo	Stock Issued During Period Value Conversion Of Advanced Subscriptions StockIssuedDuringPeriodValueConversionOfAdvancedSubscriptions	1449000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2555000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-60278000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-46596000	USD
CY2021	wejo	Adjustments To Additional Paid In Capital Convertible Debt Discount AdjustmentsToAdditionalPaidInCapitalConvertibleDebtDiscount	31289000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	106252000	USD
CY2021	wejo	Stock Issued During Period Value Conversion Of Advanced Subscriptions StockIssuedDuringPeriodValueConversionOfAdvancedSubscriptions	12757000	USD
CY2021	wejo	Stock Issued During Period Value Acquisitions Costs StockIssuedDuringPeriodValueAcquisitionsCosts	16464000	USD
CY2021	wejo	Stock Issued During Period Value Acquisitions Net Of Transaction Cost StockIssuedDuringPeriodValueAcquisitionsNetOfTransactionCost	-18496000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	52316000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2541000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-217778000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	47694000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-217778000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-60278000	USD
CY2021	wejo	Non Cash Interest Expense NonCashInterestExpense	5163000	USD
CY2020	wejo	Non Cash Interest Expense NonCashInterestExpense	1078000	USD
CY2021	wejo	Gain Loss On Issuance Of Debt GainLossOnIssuanceOfDebt	-53967000	USD
CY2020	wejo	Gain Loss On Issuance Of Debt GainLossOnIssuanceOfDebt	-16036000	USD
CY2021	wejo	Gain Loss On Issuance Of Forward Purchase Agreement GainLossOnIssuanceOfForwardPurchaseAgreement	-11674000	USD
CY2020	wejo	Gain Loss On Issuance Of Forward Purchase Agreement GainLossOnIssuanceOfForwardPurchaseAgreement	0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-25598000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	52316000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1354000	USD
CY2021	wejo	Gain Loss On Settlement Of Forward Purchase Agreement GainLossOnSettlementOfForwardPurchaseAgreement	399000	USD
CY2020	wejo	Gain Loss On Settlement Of Forward Purchase Agreement GainLossOnSettlementOfForwardPurchaseAgreement	0	USD
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4000	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-58000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4411000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4077000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-338000	USD
CY2021	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-4470000	USD
CY2020	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-1878000	USD
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	12922000	USD
CY2020	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-11133000	USD
CY2021	wejo	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	13800000	USD
CY2020	wejo	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	0	USD
CY2021	wejo	Change In Fair Value Of Forward Purchase Agreement ChangeInFairValueOfForwardPurchaseAgreement	-15609000	USD
CY2020	wejo	Change In Fair Value Of Forward Purchase Agreement ChangeInFairValueOfForwardPurchaseAgreement	0	USD
CY2021	wejo	Unrealized Gain Loss On Exchangeable Right Liability UnrealizedGainLossOnExchangeableRightLiability	34452000	USD
CY2020	wejo	Unrealized Gain Loss On Exchangeable Right Liability UnrealizedGainLossOnExchangeableRightLiability	0	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	727000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	400000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9775000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	90000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1361000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2647000	USD
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	12516000	USD
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	2023000	USD
CY2021	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	282000	USD
CY2020	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-106566000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21500000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	562000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	55000	USD
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2716000	USD
CY2020	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1810000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3278000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1865000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	122717000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1004000	USD
CY2021	us-gaap	Proceeds From Sale Of Interest In Corporate Unit ProceedsFromSaleOfInterestInCorporateUnit	70308000	USD
CY2020	us-gaap	Proceeds From Sale Of Interest In Corporate Unit ProceedsFromSaleOfInterestInCorporateUnit	0	USD
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	606000	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2086000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2021	wejo	Proceeds From Issuance Of Advance Of Subscription ProceedsFromIssuanceOfAdvanceOfSubscription	0	USD
CY2020	wejo	Proceeds From Issuance Of Advance Of Subscription ProceedsFromIssuanceOfAdvanceOfSubscription	348000	USD
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	16222000	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	25222000	USD
CY2021	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	0	USD
CY2020	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	84000	USD
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	31865000	USD
CY2020	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2021	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	84000	USD
CY2020	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	USD
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	9862000	USD
CY2021	wejo	Settlement Of Forward Purchase Agreement SettlementOfForwardPurchaseAgreement	2517000	USD
CY2020	wejo	Settlement Of Forward Purchase Agreement SettlementOfForwardPurchaseAgreement	0	USD
CY2021	wejo	Advance Payment Of Forward Purchase Agreement AdvancePaymentOfForwardPurchaseAgreement	75012000	USD
CY2020	wejo	Advance Payment Of Forward Purchase Agreement AdvancePaymentOfForwardPurchaseAgreement	0	USD
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	10142000	USD
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	159441000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35668000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3304000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-370000000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	823000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	52901000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13126000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14421000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1295000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67322000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14421000	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	90000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2021	wejo	Transaction Costs Included In Accounts Payable And Accrued Expenses TransactionCostsIncludedInAccountsPayableAndAccruedExpenses	8476000	USD
CY2020	wejo	Transaction Costs Included In Accounts Payable And Accrued Expenses TransactionCostsIncludedInAccountsPayableAndAccruedExpenses	0	USD
CY2021	wejo	Convertible Note Issued Through Settlement Of Accounts Payable And Recognition Of Prepaid Revenue Share Costs ConvertibleNoteIssuedThroughSettlementOfAccountsPayableAndRecognitionOfPrepaidRevenueShareCosts	4813000	USD
CY2020	wejo	Convertible Note Issued Through Settlement Of Accounts Payable And Recognition Of Prepaid Revenue Share Costs ConvertibleNoteIssuedThroughSettlementOfAccountsPayableAndRecognitionOfPrepaidRevenueShareCosts	0	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	863000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	529000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-152200000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67300000	USD
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Note 2 Restatement discloses the nature of the restatement adjustments and shows the impact of the restatement on the Consolidated Balance Sheets and Consolidated Statements of Operations and Comprehensive Loss as of and for the year ended December 31, 2020. In addition, Note 2 Restatement discloses the restated interim financial information for the relevant unaudited condensed consolidated financial statements of Legacy Wejo as of and for the three months ended March 31, 2021, the three and six months ended June 30, 2021 and the three and nine months ended September 30, 2021.
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14421000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	688000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6053000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	21162000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	320000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10946000	USD
CY2020Q4	us-gaap	Assets Assets	32428000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4890000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9891000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8120000	USD
CY2020Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	10129000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	33030000	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	6130000	USD
CY2020Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	39780000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	84000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	79024000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	wejo	Additional Paid In Capital Prior To Acquisition AdditionalPaidInCapitalPriorToAcquisition	105717000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-152173000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-294000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-46596000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32428000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1336000	USD
CY2020	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1688000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7683000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7039000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10173000	USD
CY2020	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	4077000	USD
CY2020	wejo	Costs And Operating Expenses CostsAndOperatingExpenses	30660000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-29324000	USD
CY2020	wejo	Gain Loss On The Issuance Of Debt GainLossOnTheIssuanceOfDebt	-16036000	USD
CY2020	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-11133000	USD
CY2020	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-1878000	USD
CY2020	us-gaap	Interest Expense InterestExpense	2594000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	687000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-60278000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2555000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-62833000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.66
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.66
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36285113	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36285113	shares
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1004000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-60278000	USD
CY2020	wejo	Non Cash Interest Expense NonCashInterestExpense	1078000	USD
CY2020	wejo	Gain Loss On Issuance Of Debt GainLossOnIssuanceOfDebt	-16036000	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-58000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4077000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-338000	USD
CY2020	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-1878000	USD
CY2020	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-11133000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	400000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	90000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2647000	USD
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	2023000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21500000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	55000	USD
CY2020	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1810000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1865000	USD
CY2020	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	84000	USD
CY2020	wejo	Proceeds From Issuance Of Advance Of Subscription ProceedsFromIssuanceOfAdvanceOfSubscription	348000	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	25222000	USD
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	9862000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35668000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	823000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13126000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1295000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14421000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	529000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20467000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	636000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5088000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	26191000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	387000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10407000	USD
CY2021Q1	us-gaap	Assets Assets	36985000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6355000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7894000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9474000	USD
CY2021Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	10141000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	33864000	USD
CY2021Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	6937000	USD
CY2021Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	126063000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	166864000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	125362000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-254530000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-865000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-129879000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36985000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15275000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	609000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10976000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	26860000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	485000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10297000	USD
CY2021Q2	us-gaap	Assets Assets	37642000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4808000	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14754000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	12814000	USD
CY2021Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	177000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	32553000	USD
CY2021Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	7894000	USD
CY2021Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	97808000	USD
CY2021Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	17113000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	155368000	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	137006000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-254276000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-610000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-117726000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37642000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8611000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	930000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12577000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	22118000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	603000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9917000	USD
CY2021Q3	us-gaap	Assets Assets	32638000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	7282000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20957000	USD
CY2021Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	34000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	28273000	USD
CY2021Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	8809000	USD
CY2021Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	92262000	USD
CY2021Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	26313000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	155657000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	149758000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-275147000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2211000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-123019000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32638000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	305000	USD
CY2021Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	799000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2618000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2567000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2237000	USD
CY2021Q1	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	1025000	USD
CY2021Q1	wejo	Costs And Operating Expenses CostsAndOperatingExpenses	9246000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8941000	USD
CY2021Q1	wejo	Gain Loss On The Issuance Of Debt GainLossOnTheIssuanceOfDebt	-33301000	USD
CY2021Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-56902000	USD
CY2021Q1	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-1272000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	1862000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-79000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-102357000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-571000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-102928000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.81
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.81
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36463696	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36463696	shares
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	542000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	847000	USD
CY2021Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1543000	USD
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	2342000	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3877000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6495000	USD
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3572000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6139000	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5712000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7949000	USD
CY2021Q2	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	1130000	USD
	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	2155000	USD
CY2021Q2	wejo	Costs And Operating Expenses CostsAndOperatingExpenses	15834000	USD
	wejo	Costs And Operating Expenses CostsAndOperatingExpenses	25080000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-15292000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24233000	USD
CY2021Q2	wejo	Gain Loss On The Issuance Of Debt GainLossOnTheIssuanceOfDebt	-20666000	USD
	wejo	Gain Loss On The Issuance Of Debt GainLossOnTheIssuanceOfDebt	-53967000	USD
CY2021Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	42033000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-14869000	USD
CY2021Q2	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-3360000	USD
	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-4632000	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	2455000	USD
	us-gaap	Interest Expense InterestExpense	4317000	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-85000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	254000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-102103000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	255000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-316000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	509000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-102419000	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.80
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.80
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36463696	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36463696	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39343859	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36463696	shares
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	351000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1198000	USD
CY2021Q3	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	888000	USD
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1864000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7691000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14075000	USD
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4963000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10947000	USD
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6665000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16246000	USD
CY2021Q3	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	1108000	USD
	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	3263000	USD
CY2021Q3	wejo	Costs And Operating Expenses CostsAndOperatingExpenses	21315000	USD
	wejo	Costs And Operating Expenses CostsAndOperatingExpenses	46395000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-20964000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-45197000	USD
CY2021Q3	wejo	Gain Loss On The Issuance Of Debt GainLossOnTheIssuanceOfDebt	0	USD
	wejo	Gain Loss On The Issuance Of Debt GainLossOnTheIssuanceOfDebt	-53967000	USD
CY2021Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	3268000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-11601000	USD
CY2021Q3	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	162000	USD
	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-4470000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	2954000	USD
	us-gaap	Interest Expense InterestExpense	7271000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-383000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-468000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-20871000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2821000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-122974000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2505000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18050000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-120469000	USD
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.35
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37162062	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37162062	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36699038	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36699038	shares
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-102357000	USD
CY2021Q1	wejo	Non Cash Interest Expense NonCashInterestExpense	801000	USD
CY2021Q1	wejo	Gain Loss On Issuance Of Debt GainLossOnIssuanceOfDebt	-33301000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1025000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	80000	USD
CY2021Q1	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-1272000	USD
CY2021Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-56902000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-52000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3154000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1442000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-4119000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8607000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	126000	USD
CY2021Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	316000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-442000	USD
CY2021Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	16115000	USD
CY2021Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	84000	USD
CY2021Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	17000	USD
CY2021Q1	wejo	Payments Of Deferred Financing Costs PaymentsOfDeferredFinancingCosts	100000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14950000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	145000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6046000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14421000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20467000	USD
CY2021Q1	wejo	Deferred Offering Costs Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses	2070000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-102103000	USD
	wejo	Non Cash Interest Expense NonCashInterestExpense	2245000	USD
	wejo	Gain Loss On Issuance Of Debt GainLossOnIssuanceOfDebt	-53967000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2155000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	96000	USD
	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-4632000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-14869000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-79000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2795000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2547000	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	10000000	USD
	wejo	Payments Of Deferred Financing Costs PaymentsOfDeferredFinancingCosts	400000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21396000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-358000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19272000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	251000	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1250000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1501000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	16222000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	17265000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	84000	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	35000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	231000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	854000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14421000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15275000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	482000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	45000	USD
	wejo	Deferred Offering Costs Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses	5404000	USD
	wejo	Convertible Note Issued Through Settlement Of Accounts Payable And Recognition Of Prepaid Revenue Share Costs ConvertibleNoteIssuedThroughSettlementOfAccountsPayableAndRecognitionOfPrepaidRevenueShareCosts	4832000	USD
	us-gaap	Interest Paid Net InterestPaidNet	863000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-122974000	USD
	wejo	Non Cash Interest Expense NonCashInterestExpense	4230000	USD
	wejo	Gain Loss On Issuance Of Debt GainLossOnIssuanceOfDebt	-53967000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3263000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-527000	USD
	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-4470000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-11601000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	244000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3662000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5171000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	6404000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29927000	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2136000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2618000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	16222000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	25631000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	638000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	84000	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	10143000	USD
	wejo	Payments Of Deferred Financing Costs PaymentsOfDeferredFinancingCosts	3148000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	26836000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-101000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5810000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14421000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8611000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	40000	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	12757000	USD
	wejo	Deferred Offering Costs Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses	5392000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Financial instruments that subject the Company to credit risk consist solely of cash. The Company places cash in established financial institutions. The Company has no significant off-balance-sheet risk or concentration of credit risk, such as foreign exchange contracts, options contracts, or other foreign hedging arrangements.
	wejo	Convertible Note Issued Through Settlement Of Accounts Payable And Recognition Of Prepaid Revenue Share Costs ConvertibleNoteIssuedThroughSettlementOfAccountsPayableAndRecognitionOfPrepaidRevenueShareCosts	4714000	USD
	us-gaap	Interest Paid Net InterestPaidNet	863000	USD
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65625896	shares
CY2021	wejo	Earn Out Distribution Period EarnOutDistributionPeriod	P7Y
CY2021Q4	wejo	Number Of Shares Authorized For Earn Out Distribution NumberOfSharesAuthorizedForEarnOutDistribution	6000000	shares
CY2021	wejo	Business Combination Number Of Trading Days BusinessCombinationNumberOfTradingDays	P20D
CY2021	wejo	Business Combination Number Of Consecutive Trading Days Within Earnout Period BusinessCombinationNumberOfConsecutiveTradingDaysWithinEarnoutPeriod	P30D
CY2021	us-gaap	Use Of Estimates UseOfEstimates	The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the fair value of the common shares, derivative liability, Advanced Subscription Agreements, Forward Purchase Agreement, exchangeable right liability, warrant liabilities, income taxes, software development costs and the estimate of useful lives with respect to developed software, warrants, and accounting for share-based compensation. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ materially from those estimates.
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	400000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q3	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	0	USD
CY2021Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	USD
CY2020Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021Q4	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	12650000	USD
CY2021Q4	wejo	Forward Purchase Agreement ForwardPurchaseAgreement	45611000	USD
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	45611000	USD
CY2021Q4	wejo	Exchangeable Right Liability Noncurrent ExchangeableRightLiabilityNoncurrent	11154000	USD
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	23804000	USD
CY2020Q4	wejo	Advanced Subscription Agreement Fair Value AdvancedSubscriptionAgreementFairValue	8120000	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	39780000	USD
CY2020Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	47900000	USD
CY2021Q4	wejo	Derivative Liability Term DerivativeLiabilityTerm	P0Y
CY2020	wejo	Derivative Liability Term DerivativeLiabilityTerm	P0Y3M18D
CY2021Q4	wejo	Exchangeable Right Liability Term ExchangeableRightLiabilityTerm	P5Y
CY2021Q4	wejo	Exchangeable Right Liability Term ExchangeableRightLiabilityTerm	P4Y10M24D
CY2021Q4	wejo	Forward Purchase Agreement Term ForwardPurchaseAgreementTerm	P2Y
CY2021Q4	wejo	Forward Purchase Agreement Term ForwardPurchaseAgreementTerm	P1Y10M24D
CY2021	wejo	Unrealized Gain Loss On Forward Purchase Agreement UnrealizedGainLossOnForwardPurchaseAgreement	-15600000	USD
CY2021	wejo	Reduction Of Revenue Arising From Revenue Sharing ReductionOfRevenueArisingFromRevenueSharing	3700000	USD
CY2020	wejo	Reduction Of Revenue Arising From Revenue Sharing ReductionOfRevenueArisingFromRevenueSharing	2400000	USD
CY2021Q4	wejo	Forward Purchase Agreement Current ForwardPurchaseAgreementCurrent	45600000	USD
CY2021	wejo	Gain Loss On Issuance Of Forward Purchase Agreement GainLossOnIssuanceOfForwardPurchaseAgreement	-11700000	USD
CY2021	wejo	Gain Loss On Settlement Of Forward Purchase Agreement GainLossOnSettlementOfForwardPurchaseAgreement	400000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	12338000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1001000	USD
CY2021Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	2963000	USD
CY2020Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	425000	USD
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1346000	USD
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	0	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	600000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	296000	USD
CY2021Q4	wejo	Research And Development Expenditure Credit Receivable Current ResearchAndDevelopmentExpenditureCreditReceivableCurrent	271000	USD
CY2020Q4	wejo	Research And Development Expenditure Credit Receivable Current ResearchAndDevelopmentExpenditureCreditReceivableCurrent	331000	USD
CY2021Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	0	USD
CY2020Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	4000000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17518000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6053000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1391000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	751000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	740000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	431000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	651000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	320000	USD
CY2021	us-gaap	Depreciation Depreciation	300000	USD
CY2020	us-gaap	Depreciation Depreciation	200000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25530000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16041000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9489000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23039000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12093000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10946000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1467000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9489000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3465000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2567000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1990000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13761000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2076000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4903000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1080000	USD
CY2020Q4	wejo	Accrued Marketing And Commission Cost Current AccruedMarketingAndCommissionCostCurrent	131000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1456000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1223000	USD
CY2021Q4	wejo	Accrued Development And Technology Cost Current AccruedDevelopmentAndTechnologyCostCurrent	635000	USD
CY2020Q4	wejo	Accrued Development And Technology Cost Current AccruedDevelopmentAndTechnologyCostCurrent	355000	USD
CY2021Q4	wejo	Accrued Marketing And Commission Cost Current AccruedMarketingAndCommissionCostCurrent	334000	USD
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0	USD
CY2020Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	4000000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1026000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21089000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9891000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	39000000	USD
CY2021	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-4500000	USD
CY2020	wejo	Gain Loss From Change In Fair Value Of Advanced Subscription Agreements GainLossFromChangeInFairValueOfAdvancedSubscriptionAgreements	-1900000	USD
CY2021	wejo	Debt Instrument Redemption Premium Percentage Of Outstanding Principal Amount DebtInstrumentRedemptionPremiumPercentageOfOutstandingPrincipalAmount	1
CY2020	wejo	Gain Loss On The Issuance Of Debt GainLossOnTheIssuanceOfDebt	-16000000	USD
CY2021	wejo	Gain Loss On The Issuance Of Debt GainLossOnTheIssuanceOfDebt	-54000000	USD
CY2020Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	39800000	USD
CY2020	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-11100000	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	6100000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	20700000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-25600000	USD
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	12900000	USD
CY2021	us-gaap	Accretion Expense AccretionExpense	3600000	USD
CY2020	us-gaap	Accretion Expense AccretionExpense	1100000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	5295000	USD
CY2021Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	33705000	USD
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2696120	shares
CY2021	wejo	Warrants Issued During The Period WarrantsIssuedDuringThePeriod	11500000	shares
CY2021	wejo	Warrants Exercised WarrantsExercised	2696120	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11500000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65625896	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	148000000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.464
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.013
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.04
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52316000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-217421000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-195416000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-59874000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-60278000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	357000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	357000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.190
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.190
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.070
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.066
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.020
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.059
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2021	wejo	Effective Income Tax Rate Reconciliation Deferred True Up EffectiveIncomeTaxRateReconciliationDeferredTrueUp	-0.019
CY2020	wejo	Effective Income Tax Rate Reconciliation Deferred True Up EffectiveIncomeTaxRateReconciliationDeferredTrueUp	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.143
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.124
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	55862000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	25105000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	437000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	56299000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	25105000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	55261000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	22511000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1038000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2594000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	194000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	86000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	40000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	201000	USD
CY2021Q4	wejo	Deferred Tax Liabilities Discount On Debt DeferredTaxLiabilitiesDiscountOnDebt	0	USD
CY2020Q4	wejo	Deferred Tax Liabilities Discount On Debt DeferredTaxLiabilitiesDiscountOnDebt	1747000	USD
CY2021Q4	wejo	Deferred Tax Liabilities Accrual Adjustments DeferredTaxLiabilitiesAccrualAdjustments	804000	USD
CY2020Q4	wejo	Deferred Tax Liabilities Accrual Adjustments DeferredTaxLiabilitiesAccrualAdjustments	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	560000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1038000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2594000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2300000	USD
CY2020Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	23000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-217778000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-60278000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-217778000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-60278000	USD
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43553504	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43553504	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43553504	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43553504	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36285113	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36285113	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36285113	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36285113	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.00
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.00
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.66
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.66
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30783861	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4861413	shares
CY2021Q1	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	4000000	USD
CY2020Q4	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	4000000	USD
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1000000	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	500000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	975000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	920000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	948000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1029000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	529000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4401000	USD
CY2021	dei	Auditor Firm AuditorFirmId	1438

Files In Submission

Name	View Source	Status
0001864448-22-000015-index-headers.html	Edgar Link	pending
0001864448-22-000015-index.html	Edgar Link	pending
0001864448-22-000015.txt	Edgar Link	pending
0001864448-22-000015-xbrl.zip	Edgar Link	pending
a106-purchaseagreement.htm	Edgar Link	pending
a106-purchaseagreement001.jpg	Edgar Link	pending
a106-purchaseagreement002.jpg	Edgar Link	pending
a106-purchaseagreement003.jpg	Edgar Link	pending
a106-purchaseagreement004.jpg	Edgar Link	pending
a106-purchaseagreement005.jpg	Edgar Link	pending
a106-purchaseagreement006.jpg	Edgar Link	pending
a106-purchaseagreement007.jpg	Edgar Link	pending
a106-purchaseagreement008.jpg	Edgar Link	pending
a106-purchaseagreement009.jpg	Edgar Link	pending
a106-purchaseagreement010.jpg	Edgar Link	pending
a106-purchaseagreement011.jpg	Edgar Link	pending
a106-purchaseagreement012.jpg	Edgar Link	pending
a106-purchaseagreement013.jpg	Edgar Link	pending
a106-purchaseagreement014.jpg	Edgar Link	pending
a106-purchaseagreement015.jpg	Edgar Link	pending
a106-purchaseagreement016.jpg	Edgar Link	pending
a106-purchaseagreement017.jpg	Edgar Link	pending
a106-purchaseagreement018.jpg	Edgar Link	pending
a106-purchaseagreement019.jpg	Edgar Link	pending
a106-purchaseagreement020.jpg	Edgar Link	pending
a106-purchaseagreement021.jpg	Edgar Link	pending
a106-purchaseagreement022.jpg	Edgar Link	pending
a106-purchaseagreement023.jpg	Edgar Link	pending
a106-purchaseagreement024.jpg	Edgar Link	pending
a106-purchaseagreement025.jpg	Edgar Link	pending
a106-purchaseagreement026.jpg	Edgar Link	pending
a106-purchaseagreement027.jpg	Edgar Link	pending
a106-purchaseagreement028.jpg	Edgar Link	pending
a106-purchaseagreement029.jpg	Edgar Link	pending
a106-purchaseagreement030.jpg	Edgar Link	pending
a106-purchaseagreement031.jpg	Edgar Link	pending
a106-purchaseagreement032.jpg	Edgar Link	pending
a106-purchaseagreement033.jpg	Edgar Link	pending
a106-purchaseagreement034.jpg	Edgar Link	pending
a106-purchaseagreement035.jpg	Edgar Link	pending
a106-purchaseagreement036.jpg	Edgar Link	pending
a106-purchaseagreement037.jpg	Edgar Link	pending
a106-purchaseagreement038.jpg	Edgar Link	pending
a106-purchaseagreement039.jpg	Edgar Link	pending
a106-purchaseagreement040.jpg	Edgar Link	pending
a106-purchaseagreement041.jpg	Edgar Link	pending
a106-purchaseagreement042.jpg	Edgar Link	pending
a106-purchaseagreement043.jpg	Edgar Link	pending
a106-purchaseagreement044.jpg	Edgar Link	pending
a106-purchaseagreement045.jpg	Edgar Link	pending
a106-purchaseagreement046.jpg	Edgar Link	pending
a106-purchaseagreement047.jpg	Edgar Link	pending
a106-purchaseagreement048.jpg	Edgar Link	pending
a106-purchaseagreement049.jpg	Edgar Link	pending
a106-purchaseagreement050.jpg	Edgar Link	pending
a106-purchaseagreement051.jpg	Edgar Link	pending
a106-purchaseagreement052.jpg	Edgar Link	pending
a106-purchaseagreement053.jpg	Edgar Link	pending
a106-purchaseagreement054.jpg	Edgar Link	pending
a106-purchaseagreement055.jpg	Edgar Link	pending
a106-purchaseagreement056.jpg	Edgar Link	pending
a106-purchaseagreement057.jpg	Edgar Link	pending
a106-purchaseagreement058.jpg	Edgar Link	pending
a106-purchaseagreement059.jpg	Edgar Link	pending
a106-purchaseagreement060.jpg	Edgar Link	pending
a106-purchaseagreement061.jpg	Edgar Link	pending
a106-purchaseagreement062.jpg	Edgar Link	pending
a106-purchaseagreement063.jpg	Edgar Link	pending
a106-purchaseagreement064.jpg	Edgar Link	pending
a106-purchaseagreement065.jpg	Edgar Link	pending
a106-purchaseagreement066.jpg	Edgar Link	pending
a106-purchaseagreement067.jpg	Edgar Link	pending
a106-purchaseagreement068.jpg	Edgar Link	pending
a106-purchaseagreement069.jpg	Edgar Link	pending
exhibit1011-sarahlarnerc.htm	Edgar Link	pending
exhibit1011-sarahlarnerc001.jpg	Edgar Link	pending
exhibit1011-sarahlarnerc002.jpg	Edgar Link	pending
exhibit1011-sarahlarnerc003.jpg	Edgar Link	pending
exhibit1011-sarahlarnerc004.jpg	Edgar Link	pending
exhibit1011-sarahlarnerc005.jpg	Edgar Link	pending
exhibit1011-sarahlarnerc006.jpg	Edgar Link	pending
exhibit1011-sarahlarnerc007.jpg	Edgar Link	pending
exhibit1011-sarahlarnerc008.jpg	Edgar Link	pending
exhibit1011-sarahlarnerc009.jpg	Edgar Link	pending
exhibit1011-sarahlarnerc010.jpg	Edgar Link	pending
exhibit1011-sarahlarnerc011.jpg	Edgar Link	pending
exhibit1011-sarahlarnerc012.jpg	Edgar Link	pending
exhibit1011-sarahlarnerc013.jpg	Edgar Link	pending
exhibit10111-changetocon.htm	Edgar Link	pending
exhibit10111-changetocon001.jpg	Edgar Link	pending
exhibit1013-uksubxplan.htm	Edgar Link	pending
exhibit1013-uksubxplan001.jpg	Edgar Link	pending
exhibit1013-uksubxplan002.jpg	Edgar Link	pending
exhibit1013-uksubxplan003.jpg	Edgar Link	pending
exhibit1013-uksubxplan004.jpg	Edgar Link	pending
exhibit1013-uksubxplan005.jpg	Edgar Link	pending
exhibit1013-uksubxplan006.jpg	Edgar Link	pending
exhibit1014-frenchrsusub.htm	Edgar Link	pending
exhibit1014-frenchrsusub001.jpg	Edgar Link	pending
exhibit1014-frenchrsusub002.jpg	Edgar Link	pending
exhibit1014-frenchrsusub003.jpg	Edgar Link	pending
exhibit1014-frenchrsusub004.jpg	Edgar Link	pending
exhibit1014-frenchrsusub005.jpg	Edgar Link	pending
exhibit1014-frenchrsusub006.jpg	Edgar Link	pending
exhibit1015-frenchshareo.htm	Edgar Link	pending
exhibit1015-frenchshareo001.jpg	Edgar Link	pending
exhibit1015-frenchshareo002.jpg	Edgar Link	pending
exhibit1015-frenchshareo003.jpg	Edgar Link	pending
exhibit1015-frenchshareo004.jpg	Edgar Link	pending
exhibit1015-frenchshareo005.jpg	Edgar Link	pending
exhibit1015-frenchshareo006.jpg	Edgar Link	pending
exhibit1023-formofrestri.htm	Edgar Link	pending
exhibit1023-formofrestri001.jpg	Edgar Link	pending
exhibit1023-formofrestri002.jpg	Edgar Link	pending
exhibit1023-formofrestri003.jpg	Edgar Link	pending
exhibit1023-formofrestri004.jpg	Edgar Link	pending
exhibit1023-formofrestri005.jpg	Edgar Link	pending
exhibit1023-formofrestri006.jpg	Edgar Link	pending
exhibit1024-formofshareo.htm	Edgar Link	pending
exhibit1024-formofshareo001.jpg	Edgar Link	pending
exhibit1024-formofshareo002.jpg	Edgar Link	pending
exhibit1024-formofshareo003.jpg	Edgar Link	pending
exhibit1024-formofshareo004.jpg	Edgar Link	pending
exhibit1024-formofshareo005.jpg	Edgar Link	pending
exhibit1024-formofshareo006.jpg	Edgar Link	pending
exhibit1024-formofshareo007.jpg	Edgar Link	pending
exhibit1024-formofshareo008.jpg	Edgar Link	pending
exhibit1025-formofrestri.htm	Edgar Link	pending
exhibit1025-formofrestri001.jpg	Edgar Link	pending
exhibit1025-formofrestri002.jpg	Edgar Link	pending
exhibit1025-formofrestri003.jpg	Edgar Link	pending
exhibit1025-formofrestri004.jpg	Edgar Link	pending
exhibit1025-formofrestri005.jpg	Edgar Link	pending
exhibit1025-formofrestri006.jpg	Edgar Link	pending
exhibit1025-formofrestri007.jpg	Edgar Link	pending
exhibit1025-formofrestri008.jpg	Edgar Link	pending
exhibit1025-formofrestri009.jpg	Edgar Link	pending
exhibit1025-formofrestri010.jpg	Edgar Link	pending
exhibit1026-frenchrsuagr.htm	Edgar Link	pending
exhibit1026-frenchrsuagr001.jpg	Edgar Link	pending
exhibit1026-frenchrsuagr002.jpg	Edgar Link	pending
exhibit1026-frenchrsuagr003.jpg	Edgar Link	pending
exhibit1026-frenchrsuagr004.jpg	Edgar Link	pending
exhibit1026-frenchrsuagr005.jpg	Edgar Link	pending
exhibit1026-frenchrsuagr006.jpg	Edgar Link	pending
exhibit1027-frenchoption.htm	Edgar Link	pending
exhibit1027-frenchoption001.jpg	Edgar Link	pending
exhibit1027-frenchoption002.jpg	Edgar Link	pending
exhibit1027-frenchoption003.jpg	Edgar Link	pending
exhibit1027-frenchoption004.jpg	Edgar Link	pending
exhibit1027-frenchoption005.jpg	Edgar Link	pending
exhibit1027-frenchoption006.jpg	Edgar Link	pending
exhibit1027-frenchoption007.jpg	Edgar Link	pending
exhibit1028-formofrestri.htm	Edgar Link	pending
exhibit1028-formofrestri001.jpg	Edgar Link	pending
exhibit1028-formofrestri002.jpg	Edgar Link	pending
exhibit1028-formofrestri003.jpg	Edgar Link	pending
exhibit1028-formofrestri004.jpg	Edgar Link	pending
exhibit1028-formofrestri005.jpg	Edgar Link	pending
exhibit1028-formofrestri006.jpg	Edgar Link	pending
exhibit1028-formofrestri007.jpg	Edgar Link	pending
exhibit1028-formofrestri008.jpg	Edgar Link	pending
exhibit1028-formofrestri009.jpg	Edgar Link	pending
exhibit211listofsubsidia.htm	Edgar Link	pending
exhibit211listofsubsidia001.jpg	Edgar Link	pending
exhibit41-descriptionofs.htm	Edgar Link	pending
exhibit41-descriptionofs001.jpg	Edgar Link	pending
exhibit41-descriptionofs002.jpg	Edgar Link	pending
exhibit41-descriptionofs003.jpg	Edgar Link	pending
exhibit41-descriptionofs004.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-kcertification963.htm	Edgar Link	pending
form10-kcertification963001.jpg	Edgar Link	pending
form10-kcertification9a2.htm	Edgar Link	pending
form10-kcertification9a2001.jpg	Edgar Link	pending
form10-kcertificationdc5.htm	Edgar Link	pending
form10-kcertificationdc5001.jpg	Edgar Link	pending
form10-kcertificationex3.htm	Edgar Link	pending
form10-kcertificationex3001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wejo-20211231.htm	Edgar Link	pending
wejo-20211231.xsd	Edgar Link	pending
wejo-20211231_cal.xml	Edgar Link	unprocessable
wejo-20211231_def.xml	Edgar Link	unprocessable
wejo-20211231_g1.jpg	Edgar Link	pending
wejo-20211231_htm.xml	Edgar Link	completed
wejo-20211231_lab.xml	Edgar Link	unprocessable
wejo-20211231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Wejo Group Ltd

2021 Q4 Form 10-K Financial Statement

#000186444822000015 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission